Steward Partners Investment Advisory
COLL icon

Steward Partners Investment Advisory’s Collegium Pharmaceutical COLL Stock Holding History

Steward Partners Investment Advisory’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$290 Buy
+8
New +$273 ﹤0.01% 4501
2025
Q2 		– Sell
-31
Closed -$925 – 4147
2025
Q1 		$925 Hold
31
– – ﹤0.01% 3785
2024
Q4 		$888 Buy
+31
New +$1.03K ﹤0.01% 3778

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Steward Partners Investment Advisory's COLL Position: Q2 2026 in Review

Steward Partners Investment Advisory opened a new position in Collegium Pharmaceutical (COLL) in Q2 2026: 8 shares worth $290. The stake represents ﹤0.01% of the portfolio and ranks #4501 among its holdings. This is a return to the name: Steward Partners Investment Advisory previously reported a position in COLL as recently as Q1 2025.

Steward Partners Investment Advisory first reported a position in COLL in Q4 2024 and has held it in 3 quarters since. The position peaked at $925 in Q1 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Steward Partners Investment Advisory held 8 shares of Collegium Pharmaceutical worth $290 as of Q2 2026.
  • Collegium Pharmaceutical was a new Steward Partners Investment Advisory position in Q2 2026.
  • Collegium Pharmaceutical made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #4501 holding.
  • Steward Partners Investment Advisory first reported a position in Collegium Pharmaceutical in Q4 2024 and has held it in 3 quarters since.
  • Steward Partners Investment Advisory's Collegium Pharmaceutical position peaked at $925 in Q1 2025.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.